# Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal Concentrations of Von Willebrand Factor

> **NCT04555785** · PHASE4 · RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 120 (estimated)

## Conditions studied

- Bleeding

## Interventions

- **DRUG:** Wilate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04555785
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2027-11
- **Final completion:** 2028-11
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04555785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04555785, "Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal Concentrations of Von Willebrand Factor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04555785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
